Found: 64
Select item for more details and to access through your institution.
In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3117, doi. 10.3390/cells11193117
- By:
- Publication type:
- Article
The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.
- Published in:
- British Journal of Pharmacology, 2014, v. 171, n. 7, p. 1722, doi. 10.1111/bph.12568
- By:
- Publication type:
- Article
Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin- A1 and its N-terminal-derived peptide Ac- ANX- A1<sub>2-26</sub>.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 1, p. 238, doi. 10.1111/j.1476-5381.2012.02176.x
- By:
- Publication type:
- Article
The pro‐resolving mediator, annexin A1 regulates blood pressure, and age‐associated changes in cardiovascular function and remodeling.
- Published in:
- FASEB Journal, 2024, v. 38, n. 3, p. 1, doi. 10.1096/fj.202301802R
- By:
- Publication type:
- Article
B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2013, v. 40, n. 4, p. 253, doi. 10.1111/1440-1681.12070
- By:
- Publication type:
- Article
Myocardial insulin resistance, metabolic stress and autophagy in diabetes.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2013, v. 40, n. 1, p. 56, doi. 10.1111/j.1440-1681.2012.05738.x
- By:
- Publication type:
- Article
Reactive oxygen species and insulin-resistant cardiomyopathy.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2010, v. 37, n. 2, p. 222, doi. 10.1111/j.1440-1681.2009.05274.x
- By:
- Publication type:
- Article
Correspondence: Reply to 'Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury'.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02656-0
- By:
- Publication type:
- Article
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14232, doi. 10.1038/ncomms14232
- By:
- Publication type:
- Article
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Diabetic Cardiomyopathy: The Case for a Role of Fructose in Disease Etiology.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy.
- Published in:
- Diabetes, 2010, v. 59, n. 6, p. 1512, doi. 10.2337/db09-1456
- By:
- Publication type:
- Article
The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1384, doi. 10.3390/ijms21041384
- By:
- Publication type:
- Article
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01303-9
- By:
- Publication type:
- Article
CARDIAC HYPERTROPHY, SUBSTRATE UTILIZATION AND METABOLIC REMODELLING: CAUSE OR EFFECT?
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2006, v. 33, n. 1/2, p. 159, doi. 10.1111/j.1440-1681.2006.04342.x
- By:
- Publication type:
- Article
LIPOCORTIN-1 PRESERVES MYOCARDIAL RESPONSIVENESS TO β-ADRENERGIC STIMULATION IN RAT PAPILLARY MUSCLE.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1999, v. 26, n. 7, p. 522, doi. 10.1046/j.1440-1681.1999.03067.x
- By:
- Publication type:
- Article
ELIMINATION, BUT NOT ACCUMULATION, OF METOPROLOL BY RAT ISOLATED PERFUSED HEART IS SELECTIVELY....
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1998, v. 25, n. 7/8, p. 548, doi. 10.1111/j.1440-1681.1998.tb02249.x
- By:
- Publication type:
- Article
Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice.
- Published in:
- Obesity (19307381), 2015, v. 23, n. 6, p. 1166, doi. 10.1002/oby.21072
- By:
- Publication type:
- Article
Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00727
- By:
- Publication type:
- Article
Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01493
- By:
- Publication type:
- Article
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial Infarction.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00269
- By:
- Publication type:
- Article
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.
- Published in:
- Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.00114
- By:
- Publication type:
- Article
Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2020, v. 34, n. 6, p. 823, doi. 10.1007/s10557-020-07086-7
- By:
- Publication type:
- Article
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 6, p. 669, doi. 10.1007/s10557-019-06914-9
- By:
- Publication type:
- Article
Modified redox signaling in vasculature after chronic infusion of the insulin receptor antagonist, S961.
- Published in:
- Microcirculation, 2019, v. 26, n. 2, p. N.PAG, doi. 10.1111/micc.12501
- By:
- Publication type:
- Article
The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0044481
- By:
- Publication type:
- Article
Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034892
- By:
- Publication type:
- Article
Fructose Modulates Cardiomyocyte Excitation- Contraction Coupling and Ca2+ Handling In Vitro.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025204
- By:
- Publication type:
- Article
Elevated dietary sugar and the heart: experimental models and myocardial remodeling.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2010, v. 88, n. 5, p. 525, doi. 10.1139/Y10-005
- By:
- Publication type:
- Article
Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes.
- Published in:
- Scientific Reports, 2017, p. 39604, doi. 10.1038/srep39604
- By:
- Publication type:
- Article
Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid Arteries.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.585740
- By:
- Publication type:
- Article
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.603926
- By:
- Publication type:
- Article
Annexin-1 peptide Anx-1(2-26) protects adult rat cardiac myocytes from cellular injury induced by simulated ischaemia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.672252
- By:
- Publication type:
- Article
Corrigendum: Characterising an Alternative Murine Model of Diabetic Cardiomyopathy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93234-4
- By:
- Publication type:
- Article
Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.799020
- By:
- Publication type:
- Article
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.719290
- By:
- Publication type:
- Article
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes.
- Published in:
- Frontiers in Physiology, 2020, p. 1, doi. 10.3389/fphys.2020.00124
- By:
- Publication type:
- Article
Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35680-w
- By:
- Publication type:
- Article
The small‐molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti‐inflammatory in mouse precision‐cut lung slices.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2287, doi. 10.1111/bph.16231
- By:
- Publication type:
- Article
Targeting G protein‐coupled receptors for heart failure treatment.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 14, p. 2270, doi. 10.1111/bph.16099
- By:
- Publication type:
- Article
Therapeutic targets of fibrosis: Translational advances and current challenges.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 22, p. 2839, doi. 10.1111/bph.16236
- By:
- Publication type:
- Article
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 16, p. 4117, doi. 10.1111/bph.15849
- By:
- Publication type:
- Article
Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, mice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.
- Published in:
- 2020
- By:
- Publication type:
- journal article